Scleroderma (hepatobiliary manifestations)

Last revised by Daniel J Bell on 24 Nov 2020

Hepatobiliary manifestations of scleroderma are only present symptomatically in a minority of patients. Around 2.5% of patients with scleroderma develop clinically significant primary biliary cholangitis, however, antibody studies suggest that subclinical disease may be present in as many as 15% of patients.

For a general discussion of scleroderma, please refer to the parent article: scleroderma.

See also

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.